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Fractional excretion of sodium after renal transplantation. After
renal transplantation low urinary sodium concentration (UNa) has
been used to diagnose acute rejection (AR), for the early phase of
AR is often associated with reduced renal perfusion. Early post-
operative graft failure without low UN favors the diagnosis of
ischemic tubular damage (ATN). As fractional excretion of fil-
tered sodium (FENa) better reflects glomerulotubular balance in
renal sodium handling, FENa was analyzed during the first 2
weeks in 118 renal allografts. From data on 41 transplants with
good early renal function (GEF), a temporal profile of FEN was
obtained and used to evaluate the behavior of FENa by means of
standardized FENa (z score). Individual subjects followed their
own profile with a small deviation (z < 1.4 for 2 days). In 31
instances, acute rejection was diagnosed. In 14 with AR, the z
score deviated little; 2 responded to methylprednisolone given
intravenously. In 17 with AR, the z score fell significantly (z >
1.5 for 2 days), an average of 2.6 days before the first rise in
serum creatinine concentration; 15 responded to treatment. The
difference between these two groups was significant (P < 0.001).
This functional heterogeneity and different responses to treat-
ment may indicate different immunologic mechanisms which
damage different target cells in the graft in AR. In 46 patients
with acute tubular necrosis after cadaver kidney transplantation
FENa was significantly higher than it was in the GEF group as
early as the first posttransplantation day and approached normal
as the renal function recovered. This behavior Of FENa was clear-
ly different from that in AR.
Excretion fractionnelle du sodium après transplantation rénale.
Après transplantation rénale une concentration urinaire de so-
dium (UNa) faible est considerée comme on signe de rejet aigu
(AR), du fait que Ia phase précoce du rejet est souvent associée a
une diminution du debit renal. L'échec précoce d'une greffe
sans abaissement de UNa est en faveur d'une tubulopathie isché-
mique (ATN). Puisque l'excrétion fractionnelle du sodium filtré
(FENa) est le meilleur reflet de l'equilibre glomerulo-tubulaire
concernant le sodium, FENa a été ëtudiée pendant les 2 pre-
mières semaines d'évolution de 118 allogreffes rénales. A partir
de l'observation de 41 transplants ayant eu un bon fonctionne-
ment précoce (GEF) un profil de FENa en fonction du temps a été
obtenu et utilisé pour évaluer le comportement de FENa au
moyen d'une FENa standardisée (test z). Les sujets ont suivi leur
propre profil avec une deviation faible (z < 1,4 par 2 jours). Le
rejet aigu a été diagnostiqué dans 31 cas. Quatorze d'entre eux
avaient one deviation minime de z; deux ont répondu a Ia
méthylprednisolone iv. Dix sept sujets avaient une deviation
significative de z (zz > 1,5 par 2 jours), 2,6 jours en moyenne
avant Ia premiere augmentation de Ia créatinine; quinze ont
repondu au traitement. La difference entre ces deux groupes
est significative (P < 0,001). Cette hetérogeneite fonction-
nelle et cette difference de réponse au traitement peuvent
étre Ia traduction de mécanismes immunologiques différents qui
atteignent des cellules cibles de Ia greffe différentes au coors du
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rejet aigu. Chez 46 malades ayant des lesions ischémiques après
transplantation de reins de cadavre, FENa était significativement
plus elevee que dans le groupe GEF des le premier jour après Ia
transplantation et revenait vers Ia normale au fur et a mesure que
la fonction renale s'améliorait. Ce comportement de FENa est
nettement different de celui observe dans les rejets aigus.
The clinical diagnosis of acute rejection after re-
nal transplantation is made from a constellation of
clinical and laboratory clues, for there is yet no
single clear-cut method of making the diagnosis [1-
7]. None of these findings is individually pathogno-
monic for acute rejection of the kidney allograft. In
clinical practice, early diagnosis and therapy of
acute rejection are assumed to be important to pre-
vent and minimize irreversible injury to the graft
kidney from the rejection process. Thus, the clinical
picture of acute rejection is usually not allowed to
develop fully, and treatment presumably limits the
clinical manifestations of acute rejection, thereby
making the diagnosis of acute rejection even more
difficult.
From the premise that any significant episode of
acute rejection is associated with a measurable
change in renal function, the initial basis for sus-
pecting acute rejection has been an impairment of
renal function, usually a rise in serum creatinine
concentration. In practice, any increasing degree of
azotemia that is not attributable to other easily de-
finable causes is considered as probable acute rejec-
tion.
Physiologic and radiologic studies indicate that
acute rejection of the kidney allograft is frequently
associated with decreased renal perfusion [8—13],
evidenced by decreased urine volume with low so-
dium and high urinary osmolality [14], increased
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plasma renin activity [15], poor peripheral filling
on arteriogram [16], and abnormal 1311-orthoiodo-
hippurate scintiphotographic findings [17]. All of
these changes develop in the absence of systemic
hemodynamic alterations, such as hypovolemia, or
hypotension, or both, which also may result in re-
duced renal perfusion. This "inappropriate" intra-
renal ischemia is further suggested by histologic
changes in small blood vessels, for example, micro-
thrombosis, intimal swelling, fibrinoid necrosis, hy-
perplasia of the juxtaglomerular apparatus, and, oc-
casionally, "ischemic" collapse of the glomeruli
[18—22].
It is reasonable, therefore, to suspect that a phys-
iologic stage in which a glomerulotubular imbalance
with tubular preponderance might develop early in
acute rejection before subsequent tubulointerstitial
inflammation impairs tubular epithelial function.
With intact tubular function, decreased renal per-
fusion would be manifested as an altered handling
of filtered sodium even before a decrease in gb-
merular filtration can be detected [23]. In fact, low
urinary sodium concentration is a useful clinical
clue for the diagnosis of acute rejection [1—7, 13].
Physiologic considerations, however, suggest that
the appropriate way to evaluate the renal handling
of sodium would be the analysis of the fractional
excretion of filtered sodium (FENa), for this term
takes into account the actual amount of sodium fil-
tered at the glomeruli and the fraction reabsorbed
by the tubules. There are no data on the normal
concentration of urinary sodium after renal trans-
plantation to allow one to determine what is abnor-
mally low. If there is indeed a significant intrarenal
ischemia indicative of glomerulotubular imbalance
in the early stage of acute rejection, monitoring the
fractional excretion of filtered sodium should pro-
vide a clinical clue to the diagnosis of acute rejec-
tion prior to the rise in serum creatinine concentra-
tion.
Early postoperative graft failure presents a diag-
nostic problem, especially when oliguria develops
after a period of up to 24 hours of apparent normal
diuresis. It is important to distinguish reversible
graft failure secondary to ischemic tubular necrosis
from other possible causes of early anuria or oh-
guria such as acute rejection, vascular thrombosis,
and mechanical obstruction of the urinary tract.
Hyperacute rejection usually becomes apparent on
the operating table immediately after vascular
anastomosis. Acute rejection is an ever present
threat, but is seen more commonly after the first
few days of an apparently normal course. The entire
constellation of clinical findings including a variety
of laboratory data, urograms, arteriograms, and ra-
dioisotopic studies usually provide diagnostic clues.
Even with renal biopsy, however, it may at times be
impossible to differentiate with certainty between
acute tubular necrosis and an acute rejection crisis.
The presence of graft swelling with tenderness,
unexplained fever, relatively low urinary excretion
of sodium (UNa) and high urinary urea concentration
associated with worsening of renal function favor
the diagnosis of acute rejection rather than acute
tubular necrosis [24]. The diagnosis of ischemic re-
nal injury is usually one of exclusion. If all other
causes of graft failures in the very early post-
transplant period have been excluded with reason-
able certainty, one usually assumes that the diagno-
sis is acute tubular necrosis and that the kidney is
likely to recover [25].
One hundred eighteen cases who had received a
renal allograft were analyzed retrospectively to es-
tablish the temporal profile of normal FENa after
renal transplantation, to develop a technique to de-
termine abnormal values of FENa, and to evaluate
the diagnostic significance of FENa for acute rejec-
tion and acute tubular necrosis. We report two sub-
groups of acute rejection identified by different be-
havior of FENa and their different responses to con-
ventional treatment for acute rejection.
Methods
The data analyzed, retrospectively, were from
118 renal allografts done between September 1972
to July 1977 at the University of Cincinnati Medical
Center; all allografts with appropriate data for the
calculation of sequential daily FENa were included.
One hundred were cadaver kidneys, and 18 were
from living related donors. In 70 patients, both kid-
neys had been removed prior to transplantation; 48
kept their own kidneys throughout the observation
period.
Twenty-four hour urine samples were collected
through indwelling Foley catheters during post-
operative days I and 2, and thereafter by voiding
from 6:00 A.M. to 6:00 AM. The volume was record-
ed to the nearest milliliter. Serum samples were ob-
tained by venipuncture at about 7:00 A.M.1 Serum
and urine creatinine concentrations were measured
During periods of rapid change immediately after trans-
plantation, the use of the morning for the calculation of GFR
with subsequently collected 24-hour urine would underestimate
GFR and thereby overestimate FEN. This problem can be avoid-
ed if one uses spot urine specimens for UNa and Ucr obtained
concurrently with blood specimens for P. and PNa.
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by Technicon Autoanalyzer with appropriate dilu-
tion of specimen in the case of urine. Sodium con-
centration was measured by flame photometry (IL-
443).
Calculation of FENI. The calculation of FENa was
done by:
Na excreted UNa%FENa = Na filtered X 100 = PNa GFR
x 100
—
UNa V
—
(U/P)Na
UcrV
x 100 — (u/p) x 100
PNa Pcr
The patients were maintained on a regular hospi-
tal diet containing about 200 mmoles of sodium per
day as soon as the postoperative clinical condition
allowed oral intake.2 Before this, they received in-
travenous fluid infusion, replacing two thirds of the
hourly output plus 50 ml/hr with alternating bottles
of normal saline and half-normal saline. When a sig-
nificant weight gain, or rise in blood pressure, or
both occurred during rejection episodes, suggesting
salt and water retention, the dietary salt and water
were restricted moderately. When patients received
diuretics, the subsequent data on FENa could not be
interpreted and were not analyzed.
Definitions. The initial 2-week course of the renal
allografts was classified into one of the following
three categories: Good early function (41 grafts).
This diagnosis was made when there was a contin-
uing fall in serum creatinine concentration to < 2
mgldl by day 7 posttransplantation. Acute tubular
necrosis (46 grafts). This clinical diagnosis was
made by convention when the graft function de-
viated from good early function" following trans-
plantation and when the graft perfusion was judged
by the surgeon to be good postanastomosis, and lat-
er in the first week by renal scan (in most cases)
performed with 15 mCi of 99mTc in the form of Reno-
tech® (Squibb), and mechanical obstruction of the
urinary tract was ruled out. Acute rejection (31
grafts). This diagnosis was made when there was an
increase, or failure of expected decline, in serum
creatinine concentration occurring after an initial
period conforming with good early function and two
or more of the following: (a) fever, otherwise unex-
plained, (b) reduction in urine output, (c) graft
2 The amount of sodium actually taken varied widely among
patients, and from day to day in individuals. This important vari-
able was not and could not have been controlled in this retro-
spective study; as shall be seen later in this paper, it was possible
to make clinical use of FEN even under such inadequately con-
trolled conditions.
tenderness with or without enlargement of the graft,
(d) UNa < 20 mEqiliter.
Response to therapy for acute rejection was de-
fined as a return of serum creatinine concentration
towards the prerejection level within 10 days after
the initiation of treatment for rejection. This treat-
ment consisted of 250 to 500 mg i.v. of methylpred-
nisolone daily, with or without local irradiation (150
rads) of the graft every other day by 60Co. This
treatment was continued until: (a) there was an ar-
bitrary maximal cumulative dose of methyl-
prednisolone of up to 3 g, with or without a local
irradiation dose of 900 rads, (b) the serum creati-
nine concentration declined on 2 or 3 consecutive
days, (c) other clinical contraindications (such as
bacterial pneumonia or urinary tract infection) de-
veloped.
The standard immunosuppressive treatment at
the University of Cincinnati Medical Center con-
sisted of azathioprine, prednisone, and goat anti-
lymphocyte globulin (ALG). Azathioprine was giv-
en in a dose of 2 mg/kg/day from the day of trans-
plantation. This dose was reduced to 1.5 mg/kg/day
while serum creatinine was > 2 mg/dl to prevent
bone marrow suppression. Prednisone was reduced
from the initial preoperative dose of 400 mg/day,
step by step until patients were sent home with a
maintenance dose of about 1 mg/kg/day by the end
of week 3 or 4. ALG was used in low dose (2 mg/
kg/day, i.m.) for 3 weeks until 1977, thereafter in a
larger dose (15 mg/kg) intravenously 15 times over 4
weeks.
Results
Patients with good early function
Distribution of FENa. To determine the appropri-
ate mathematic methods for the analysis, we ana-
lyzed data on FENa on postoperative day 7 from 29
previously nephrectomized patients with good early
graft function. The data showed clearly that the dis-
tribution of FENa was log-normal. All subsequent
statistical analyses of FENa were done after logarith-
mic transformation and were expressed on a loga-
rithmic scale [27].
Effect of native kidneys on FE\. Because FENa is
very high in chronic renal failure [283l], it was im-
portant to assess whether there were any effects of
the presence of the diseased kidneys on FENa after
renal transplantation. The data on 29 nephrecto-
mized and 12 nonnephrectomized patients with
good early function were compared (Fig. 1) and did
not differ significantly. There was also no significant
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Fig. 1. %FEN. after renal transplantation with good early func-
tion in a group with (cross-hatched band) and a group without
(open band) nephrectomy of native diseased kidneys. The bands
cover mean 1 SD. There is no significant effect of the presence
of native diseased kidneys on FENa as long as graft function is
good.
Fig. 2. %FENA (mean I SD) after renal transplantation with
good early function (N = 41).
to evaluate the individual case (Fig. 2). The mean
FENa (+ 1 SD, — I SD) on the day of renal trans-
plantation was 14.5% (41.0%, 5.10%); on post-
operative day 1, 5.41% (13.0%, 2.25%); on day 2,
2.03% (4.30%, 0.97%); and rapidly decreased to
reach the lowest value, 0.91% (1.91%, 0.44%) on
postoperative day 7; thereafter FENa gradually rose
to 1.47% (2.05%, 1.05%) by postoperative day 14
and stayed about the same level thereafter (Fig. 2).
Calculation of z score. Because absolute values
of FENC change rapidly during an uncomplicated
course after renal transplantation, FENa values from
an individual should be evaluated in the same con-
text. For this purpose, a modification of growth-
curve techniques was used [32].
Individual FENa was standardized by means of z
transformation, that is,
z = (individual FENa — mean FENa)/SD
where mean and SD represent the mean and stan-
dard deviation of FENa of 41 patients with good
early function, calculated daily.
Figure 3 can be used at the bedside to obtain a z
score simply and graphically without having to use
the above equation. The curve corresponding to the
mean represents a z score of zero, + 1 SD repre-
Nephrectomy (N 29)
Name Chart # Date of transplantation Cad: Del
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Fig. 3. No,nogram used to obtain z score graphically at bedside.
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difference in FENa between cadaver kidney recipi-
ents and related donor kidney recipients with good
early graft function.
Establishment of the norm for FENa. FENa values
from all 41 patients with good early function were
pooled, regardless of nephrectomy status or source
of the graft, to establish a norm that would be used
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Fig. 4. Representative case of good early renal function. The
widest fluctuation of z score is 1.2 from day 12 to day 14.
sents a z score of + 1.0, — I SD represents z score of
— 1.0, and so on. The intervals between mean and
— 1 SD are partitioned into five equal divisions to
facilitate estimation of z score graphically to the
nearest tenth.
Range of z score in patients with good early renal
function. In this group of patients, FENa fluctuated
within a very narrow range of z score during the
postoperative course, despite a marked reduction in
absolute values of FENa from the immediate post-
operative period to the second postoperative week.
A representative case, whose postoperative course
was uneventful and who was judged to have had
good early function, is illustrated in Fig. 4. The
FENa was 15.0% on the day of transplantation and
1.0% on postoperative day 11. The corresponding z
score showed only a small change from 0.0 on day 1
to + 1.0 on day 6 with a slow decline to — 0.5 on
day 12.
In this group, the z score rarely changed by more
than 1.4 over a 2-day period, and there was much
less fluctuation from day to day.
Criteria of "abnormal" change in z score. From
the above observations in patients with good early
function, we used an arbitrary set of criteria to de-
termine an abnormal value of FENa or abnormal be-
havior of FENa during the postoperative course: (a)
FENa with z score of> 2.0 or < — 2.0 was assumed
to be abnormally high or abnormally low, respec-
tively, for that day; (b) changes of FENa by z of
> 1.4 over a period of 1 or 2 days. This behavior
was considered to be abnormal, that is, abnormal
drop or abnormal rise.
Urine sodium concentration in patients with good
early function. For comparison with the data on
FENa, the time course of UNa—a frequently used di-
agnostic parameter—-is plotted in Fig. 5. Ua
changed along this time course with a wide range of
"normal." On days 4 to 6, about 8% of "normals"
had UNa < 20 mEq/liter.
Patients with acute rejection
Behavior of FENa at the time of acute rejection.
In the 118 transplantations analyzed, 31 episodes of
acute rejection were diagnosed before the end of
postoperative week 2, and treatment was initiated.
Of the 31 episodes of acute rejection, 17 were as-
sociated with an abnormally low or with an abnor-
mal drop in z score for FENa immediately preceding
the first rise in serum creatinine concentration
(Figs. 6 and 7). These changes in z score for FENa
were not associated with loss of body weight or de-
crease in blood pressure, except in two patients
whose body weight decreased by 2 and 1 kg, respec-
tively. Most acute rejection episodes were accom-
panied by weight gain and rise in blood pressure.
The first appearance of an abnormally low FENa Z
score preceded the first rise in serum creatinine
concentration by 2.6 (SD) 1.6 days; in every in-
stance the change in z score occurred prior to the
clinical diagnosis of acute rejection. In no case was
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Fig. 5. U5,, (mean so) after renal transplantation with good
early function (mean SD; N = 41).
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Fig. 6. Representative case of acute rejection associated with a
significant decrease in The z score decreased by 2.1 from
day 5 to day 6, 1 day before the first rise in serum creatinine
concentration. SM indicates methyiprednisolone pulse.
an abnormal drop in z score not followed within a
week by a rise in serum creatinine concentration.
Fourteen acute rejection episodes were not asso-
ciated with any significant change in z score for
FENa before or at the time of diagnosis (Fig. 8). Six
of these had an abnormally high FENa z score soon
after rejection was diagnosed (Fig. 9).
Because one criterion for the clinical diagnosis of
acute rejection was UNa < 20 mEq/liter, we com-
pared the appearance of an abnormally low UNa and
abnormal drop in z score for FENa. Of 17 grafts with
an abnormal drop in z score, only 8 had abnormally
low UNa only 1 out of 14 without a significant drop
in z score showed abnormally low UNa. Although
the association is statistically significant (x2= 4.16,
P < 0.05), the data indicates that UNa was a poor
predictor of a fall in z score for FENa; half of the
grafts with acute rejection and a significant drop in
FENa z score did not have UNa < 20 mEq!liter.
Response of acute rejection to treatment accord-
ing to the behavior of FEy.1. Table 1 shows the re-
20
10
7
5
3
2
1.0
0.7
J0.5
0.2
0.1
0.04
0.02
2
0
—2
—3
—4
—5
6
SM
+
Sc 11.4 8.6 6.7 6.3 5.0 3.4 2.5 2.1 2.0 2.1 2.4 2.4
4 4
HD I I .t I I 'iIi
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
After transplantation, days
Fig. 7. Another example of acute rejection associated with a sig-
nificant decrease in FE,ta. The z score decreased by 2.9 from day
6 to day 7, 6 days prior to the first rise in serum creatinine con-
centration. HD indicates hemodialysis; SM is methyiprednisolone
pulse.
sponse to treatment in the 31 episodes of acute re-
jection. Of 17 patients with an abnormally low FENa
z score, 15 responded, and renal function was re-
stored to previous levels. In contrast, only 2 of 14
patients whose FENa z score did not change signifi-
cantly (z < 1.4 for 2 days) responded to treatment.
This difference in response rate is highly significant
(x2 = 14.1; P < 0.001). The 17 responders and 14
nonresponders did not differ significantly in terms
of their age, sex, history of previous trans-
plantation, nephrectomy status, and type of donor.
Of 17 patients whose FENa decreased significantly
and who did not respond to treatment, 2 lost weight
(2 kg and 1 kg, respectively) just prior to the first
rise in serum creatinine concentration.
In contrast, low UNa did not predict therapeutic
response. Of 9 patients with rejection episodes and
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Fig. 8. Representative case of acute rejection associated with
no significant change in FENa. SM and HD are defined in Fig. 7.
20
10
7
z
w 3
U-
2
1.0
0.7
0.5
4$
I I I l_l 1___l I LHDI01234567891011121314
After transplantation, days
Fig. 9. Representative case of acute rejection associated with a
significant rise in FEN,,. The z score rose by 1.7 from day 9 to day
11, 4 days after the initial rise in serum creatinine concentration:
SM and HD are defined in Fig. 7.
Table 1. Response to treatment for acute rejection according to
the behaviour of FENa
FEN,, z score during
acute rejectiona
Low Not low
Response 15 2
No response 2 12
Table 2. Graft status at 4 months according to the behavior of
FENa during initial acute rejection
FEN,, z score during
acute rejectiona
Low Not low
Functioning 16 7
Lost from renal failure 1 7"
x2 = 5.67; P < 0.002.
"There were three incorrectly diagnosed acute rejection epi-
sodes (see Discussion). If they are excluded from the analysis the
differences between the two groups are greater (x2 = 10.9; P <
0.001).
low UNa, 3 did not respond to treatment, whereas 11
of 22 patients with rejection episodes without low
UNa responded (x2 = 0.20, F> 0.5).
Graft status at 4 months posttransplantation. Be-
cause there was such a striking difference in re-
sponse to treatment according to their different be-
havior in terms of FENa, we analyzed the later out-
come of the 31 transplantations with early (within 2
weeks) rejection episodes at the end of post-
operative month 4 (Table 2). Of the 17 patients
who showed abnormally low FENa z scores dur-
ing the early rejection episode, 16 maintained
functioning grafts, as compared to only 7 of 14 pa-
tients whose FENa z score did not change signifi-
cantly at that time. This difference is significant (x2
= 5.67; P <0.02). The other 7 grafts were lost from
progressive deterioration of graft function within 4
months. Pathologic examination of nephrectomized
grafts in all 7 cases showed findings consistent with
severe rejection with or without infarction.
Patients with acute tubular necrosis
In the 118 transplantations analyzed, 46 episodes
of acute tubular necrosis were diagnosed and were
treated with hemodialysis as needed in addition to
the standard immunosuppressive treatment. All epi-
sodes of acute tubular necrosis were seen after
cadaver kidney transplantation with variable is-
chemia times. As a group, on the first day after
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Fig. 10. FENA in acute tubular necrosis with prolonged oliguria(N = 10). The background statistical norm is from Fig. 3. HD is
hemodialysis.
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Fig. 11. FEN, in acute tubular necrosis with oliguric period short-
er than 11 days. HD is hemodialysis.
transplantation, the subjects thus diagnosed
showed significantly higher FENa (mean, 14.2%
sD1 33.2, 6.04%) than did the group with good early
function (mean, 5.41% ISDI 13.0, 2.25%), and
FENa remained elevated for varying lengths of time
until renal function improved. Because of the vari-
able severity of necrosis, this group was subdivided
into three groups according to the length of oliguria,
defined as urine volume less than 500 mI/24 hr, that
is, acute tubular necrosis with prolonged oliguria
(oliguric period> 10 days, 10 subjects), acute tubu-
lar necrosis with brief oliguria (oliguric period < 10
Time, days
Fig. 12. FE5 in nonoliguric acute tubular necrosis. HD is hemo-
dialysis.
days, 24 subjects), and nonoliguric acute tubular ne-
crosis (12 subjects). The FENa data of these three
subgroups are shown in Figs. 10 to 12. In patients
with necrosis and prolonged oliguria, FENa re-
mained very high throughout the observation period
of 2 weeks posttransplantation; the mean serum
creatinine concentration on day 14 was 11.6 mg/dl.
In patients with relatively brief oliguria (average,
5.5 days), FENa was high as early as the day after
transplantation, and gradually came down towards
normal by day 12 and remained normal; the mean
serum creatinine concentration on day 14 was 4.1
mg/dl. In patients without oliguria, the course of the
FENa was similar to that in the group with a brief
oliguric phase; the mean serum creatinine concen-
tration on day 14 was 4.3 mg/dl.
In this group of 46 grafts with acute tubular ne-
crosis, a significant drop in z score for FENa (zz >
1.4/2 days) was seen on 12 occasions. Seven were
clearly associated with acute weight loss. The mean
weight loss was 2.3 (SD) 1.0 kg over 2 days; all
lost> 1.5 kg. This loss of body weight, which im-
plies a sudden change in salt and water balance, was
seen invariably in the early diuretic phase. On the
other five occasions, a significant drop in z score for
FENa was associated with either no change in body
weight or mild weight gain.
Discussion
The pathogenesis of the rejection reaction follow-
ing renal transplantation is still not well understood.
Both cell-mediated and humoral immune mecha-
nisms may be involved [33], and this may be reflect-
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ed histologically in the finding of predominant cellu-
lar rejection or predominant microvascular rejec-
tion [21]. The bimodal nature of acute rejection is
also evident when other immunologic parameters
such as circulating immune complexes [34] or anti-
bodies to donor B-lymphocytes [35] are examined.
Whether there is a functional difference between
these two morphologically and possibly immuno-
logically distinct types of rejection episodes is not
known.
Low UNa is reported in association with acute re-
jection of the allograft kidney and has been used as
a clue for the diagnosis of acute rejection [1—7].
Low UNa has been interpreted as a reflection of de-
creased renal perfusion during acute rejection [8—
10, 16, 17]. The studies on which this interpretation
was based were done in well established acute re-
jection, and only a few observations have been
made in longitudinal repetitive fashion in the same
subject [12, 13, 16]. This longitudinal study showed
reversibility of the decreased renal perfusion on
treatment of acute rejection, usually with an in-
creased dose of steroid. Morphologic observations
showed vascular changes which potentially com-
promise blood flow in untreated dog [9, 11] and im-
munosuppressed man [18, 21, 22]. A reduction in
renal perfusion was therefore considered to be an
essential feature of the early phase of acute rejec-
tion and to be reversible if treated early enough.
Ability to excrete urine with a very low sodium
concentration when renal blood flow is reduced re-
quires intact tubular function to reabsorb filtered
sodium. When tubular function is impaired, while
RBF and GFR are decreased, UNa is not lowered.
This fact has been applied in differentiating prerenal
azotemia from acute tubular necrosis [36]. Physio-
logic considerations would dictate that the better
way to evaluate renal handling of sodium as a clue
to change in renal perfusion and glomerulotubular
balance is to measure FENa, for this term takes into
account the actual amount of sodium filtered and
the fraction reabsorbed by the tubule. FENa dif-
ferentiated prerenal azotemia from acute tubular ne-
crosis better than did UNa [37]. FENa was very low
in prerenal azotemia, whereas it was significantly
elevated in acute tubular necrosis.
There are few observations on sodium handling
by the allograft kidney, especially in early post-
operative period when the risk of acute rejection is
high. Ogden and Holmes [14] classified their 53 pa-
tients according to the course of renal function dur-
ing the first 3 to 6 weeks after transplantation. The
group with acute rejection developed a late reduc-
tion in creatinine clearance after initial good func-
tion. During the rejection episodes, mean UNa de-
creased from 107 to 16 mEq/liter, and mean UNaV
decreased from 173 to 8.2 Eq/min. These changes
were considered to reflect decreased renal per-
fusion during acute rejection. No attempt was made
to study the time course of these changes. Their
normal group, with no reduction in creatinine clear-
ance, was subdivided into two: one with no pat-
tern of urinary solute change" and the other with a
fall in UNa and UNaV. The last subgroup was consid-
ered to be dehydrated. Therefore, a fall in UNa and
UNaV was of diagnostic value for acute rejection on-
ly in the presence of an unchanged creatinine clear-
ance.
Chisholm et a! [38] reported that 13 of 20 rejection
episodes, which developed within 4 months, were
associated with a fall in 24-hour UNaV. They report-
ed that this was not an early change in the course of
acute rejection and that it was not diagnostically
significant. As 24-hour UNaV was not correlated
with GFR nor with total urine volume, change in
UNaV could not give any insight into the renal per-
fusion status or glomerulotubular relationship in so-
dium handling. Seven rejection episodes occurred
which were not associated with a fall in 24-hour
urine sodium, and were not discussed further.
We have examined carefully, in longitudinal fash-
ions, the rejection episodes developing within the
first 2 posttransplantation weeks. Two distinct
groups of acute rejection were identified according
to the behavior of the FENa. One showed a signifi-
cant decrease in FENa; the other showed no such
change. In the first group, the rapid decrease in
FENa prior to the first rise in serum creatinine con-
centration is consistent with decreased renal per-
fusion from local mechanisms, for there was no sys-
temic factor, such as volume contraction and/or
hypotension, which might have affected the renal
circulation. The result of treatment for acute rejec-
tion in this group (response in 15/17) was signifi-
cantly better than in the other group which did not
show any such change in FENa at the time of onset
of acute rejection (response in 2/14). The same cri-
teria were used for the clinical diagnosis of acute
rejection, and flO clinical distinction could be made
between these two groups of acute rejection, except
for the FENa and response to treatment. The second
group may not, of course, have had a true acute re-
jection episode. If indeed this group did not, it in-
dicates the nonspecificity of the conventional clini-
cal criteria for the diagnosis of acute rejection. On
the other hand, the unresponsiveness to conven-
176 Hong et a!
tional treatment cannot exclude the diagnosis of
acute rejection, for it presumes without grounds
that all acute rejections are responsive.
Failure to drop the FENa in the second group may
be simply a reflection of more severe damage to tu-
bules, and this could be the real reason why the
therapeutic response is so poor in this group. It
may, however, be postulated that the second group
did not have a decreased renal perfusion at the be-
ginning of acute rejection and that some other phys-
iologic or perhaps immunologic mechanism was in-
volved in the acute deterioration of renal function,
conceivably direct tubular damage without initial
vascular involvement. Although no histologic study
was performed at the time of onset, the subsequent
histologic findings in all 7 nephrectomized grafts
from the second group within a 4-month period
showed the changes consistent with advanced re-
jection. Because of advanced pathologic changes in
these kidneys, it was not possible to determine the
predominant pattern of histologic changes. The sub-
sequent hospital course of several patients in the
second group revealed possible factors other than
acute rejection which might have contributed, at
least in part, to deterioration of renal function: un-
noticed partial ureteric obstruction by a blood clot
(1 patient), partial obstruction suggested by a di-
lated ureter (1 patient), urinary tract infection (1 pa-
tient), and perinephric wound infection (1 patient).
Three of these eventually recovered graft function
and were functioning well by the fourth month. The
fourth patient, with perinephric infection, under-
went graft nephrectomy on day 79; severe rejection
was found. One may argue that the 3 patients whose
renal functions recovered eventually were errone-
ously included into the group of acute rejection. If
these three patients were excluded from the analy-
sis (Table 2), it would make the notion stronger that
acute rejection without a drop in FENa z score had a
poor prognosis (x2 = 10.9, P < 0.001).
Whether these two groups of acute rejection were
mediated by different immunologic mechanisms
cannot be known from this study. Whatever the
pathogenetic mechanisms, the different responses
to conventional treatment are striking. Furthermore
the functional pattern during the early acute rejec-
tion episodes has prognostic value for graft surviv-
al. A prospective study on early acute rejection,
correlating the pathophysiology of sodium han-
dling, predominant histologic pattern, various im-
munologic parameters, and hopefully measurement
of RBF would be very rewarding.
Although UNa <20 mEq/liter has often been used
as one criterion for the clinical diagnosis of acute
rejection after renal transplantation, there are no
data to show the range of UNa in normal (or un-
eventful) allografts. It was found that UNa also
changed along the course posttransplantation with a
rather wide range of "normal" (Fig. 5). Thus, on
the posttransplantation day 4 to 6, about 8% of
"normals" had UNa < 20 mEq/liter. The data clear-
ly demonstrate that a low UNa (< 20 mEq/liter) was
less helpful than was change in FENa in diagnosis of
acute rejection episodes, and was of no value in pre-
dicting the response to treatment.
Standardized FENa score (z) is useful for early di-
agnosis of acute rejection. A significant decrease in
FENa z score (z> 1.4) without a decrease in body
weight predicts a good response to conventional
treatment, whereas a rise in serum creatinine con-
centration without a preceding decrease in FENa Z
score makes the diagnosis of acute rejection respon-
sive to conventional treatment unlikely. With the
latter combination of laboratory data, factors other
than acute rejection should be sought, and graft
biopsy is probably indicated for diagnostic pur-
poses. This type of acute rejection (no decrease in
FENa z score) is usually not responsive to conven-
tional treatment and carries a poor prognosis for
graft survival.
The data clearly showed that the presence of the
native diseased kidney did not alter the temporal
profile of FENa after uneventful transplantation
(Fig. 1). To what extent the native kidney obliter-
ates the salt retention by the allograft undergoing
acute rejection and thereby prevents a decrease in z
FENa is not known and cannot be evaluated unless a
separate collection of urine from both old and new
kidneys is made. If the old kidney masks the drop in
Z FENa during acute rejection, however, one might
expect such episodes of acute rejection, without ne-
phrectomy of the native kidneys (possibly high
FENa), to respond to treatment in the same way as
those who showed a decreased FENa with the native
kidneys removed previously. This was not the case,
and the proportion of nephrectomized patients in
the responders and nonresponders was not signifi-
cantly different.
There is always a difficult practical problem in
differentiating acute rejection from acute tubular
necrosis in immediate postoperative graft failure.
Some workers use antirejection therapy routinely
when graft function deteriorates after good initial
diuresis [39]. The problem is further complicated by
the heterogeneity in the severity of ischemic tubular
damage as shown in this paper. Some practitioners,
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therefore, haif-heartedly initiate antirejection thera-
py when they think the recovery from acute tubular
necrosis to be unusually" slow, suspecting acute
rejection might have been superimposed upon acute
tubular necrosis. Of the 46 patients with acute tubu-
lar necrosis in this series, 12 received antirejection
treatments starting anywhere between day 7 to day
13 for the suspected acute rejection superimposing
upon tubular necrosis. It was difficult to judge the
results of these treatments. There was no secondary
rise in the serum creatinine concentration prior to
the treatment, no biopsy was done before the start
of anti-rejection treatment, and the subsequent
course was not different from that in the rest of the
group. There were 12 patients who showed a signifi-
cant drop in z score for FENa during the course of
acute tubular necrosis; 7 of these 12 were associat-
ed with a significant acute weight loss in the early
diuretic phase, probably due to dehydration.
It is shown in this paper that FENa in acute tubu-
lar necrosis is clearly higher than it is in good early
function or acute rejection, providing a useful diag-
nostic clue especially in early graft failure in cadav-
er kidney transplantation. Drops in FENa should be
interpreted in conjunction with state of fluid bal-
ance, particularly in the early diuretic phase.
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